Altoida
Washington
About Altoida
Altoida is creating a new gold standard in brain health with Precision Neurology. We're radically transforming the method for measuring brain function and diagnosing neurological disease, using just your smartphone or tablet. Our products are backed by more than 20 years of innovative research in digital biomarkers, augmented reality (AR), and artificial intelligence (AI). Altoida received FDA Breakthrough Device Designation in July 2021. Our first device is a Computerized Cognitive Assessment Aid that is classified as Class II, 510(k) exempt.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $24.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2022)
- Website: altoida.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Augmented Reality, Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/altoida-19485 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.